TYK2 and rheumatoid arthritis: Anti-IL-20 has been tested in RA and the IL-20R axis is part of the target of inhibitors of downstream signaling molecules such as Janus kinase 1, Tyrosine kinase 2 and signal transducer and activator of transcription 3 [6, 28, 46].